CN104293766A - Method of cloning goat IGFBP3 gene cDNA coding sequence - Google Patents
Method of cloning goat IGFBP3 gene cDNA coding sequence Download PDFInfo
- Publication number
- CN104293766A CN104293766A CN201310294920.4A CN201310294920A CN104293766A CN 104293766 A CN104293766 A CN 104293766A CN 201310294920 A CN201310294920 A CN 201310294920A CN 104293766 A CN104293766 A CN 104293766A
- Authority
- CN
- China
- Prior art keywords
- goat
- sequence
- gene
- cdna
- primer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000283707 Capra Species 0.000 title claims abstract description 24
- 239000002299 complementary DNA Substances 0.000 title claims abstract description 24
- 101150009635 IGFBP3 gene Proteins 0.000 title claims abstract description 15
- 238000000034 method Methods 0.000 title claims abstract description 15
- 108091026890 Coding region Proteins 0.000 title claims abstract description 14
- 238000010367 cloning Methods 0.000 title abstract description 13
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 15
- 241001494479 Pecora Species 0.000 claims abstract description 8
- 238000013461 design Methods 0.000 claims abstract description 8
- 108091081024 Start codon Proteins 0.000 claims abstract description 5
- 238000011084 recovery Methods 0.000 claims abstract description 5
- 238000011144 upstream manufacturing Methods 0.000 claims abstract description 4
- 239000002773 nucleotide Substances 0.000 claims abstract description 3
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 3
- 239000000203 mixture Substances 0.000 claims description 9
- 238000006243 chemical reaction Methods 0.000 claims description 8
- 238000012163 sequencing technique Methods 0.000 claims description 6
- 238000010839 reverse transcription Methods 0.000 claims description 3
- 210000002966 serum Anatomy 0.000 claims description 3
- 102000004190 Enzymes Human genes 0.000 claims description 2
- 108090000790 Enzymes Proteins 0.000 claims description 2
- 210000003205 muscle Anatomy 0.000 claims description 2
- 108020005038 Terminator Codon Proteins 0.000 claims 1
- 238000000137 annealing Methods 0.000 claims 1
- 230000004087 circulation Effects 0.000 claims 1
- 238000004925 denaturation Methods 0.000 claims 1
- 230000036425 denaturation Effects 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 230000001954 sterilising effect Effects 0.000 claims 1
- 108091032973 (ribonucleotides)n+m Proteins 0.000 abstract description 11
- 108020004705 Codon Proteins 0.000 abstract description 4
- 238000012408 PCR amplification Methods 0.000 abstract description 3
- 238000000746 purification Methods 0.000 abstract description 3
- 238000011161 development Methods 0.000 abstract description 2
- 238000011160 research Methods 0.000 abstract description 2
- 239000000047 product Substances 0.000 description 14
- 239000012634 fragment Substances 0.000 description 13
- 239000007788 liquid Substances 0.000 description 13
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 11
- 108020004414 DNA Proteins 0.000 description 10
- 102000013275 Somatomedins Human genes 0.000 description 8
- 238000005516 engineering process Methods 0.000 description 8
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
- 239000000499 gel Substances 0.000 description 6
- 102000004374 Insulin-like growth factor binding protein 3 Human genes 0.000 description 5
- 108090000965 Insulin-like growth factor binding protein 3 Proteins 0.000 description 5
- 102000028416 insulin-like growth factor binding Human genes 0.000 description 5
- 108091022911 insulin-like growth factor binding Proteins 0.000 description 5
- 239000006228 supernatant Substances 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 102000004218 Insulin-Like Growth Factor I Human genes 0.000 description 3
- 239000011543 agarose gel Substances 0.000 description 3
- 238000000246 agarose gel electrophoresis Methods 0.000 description 3
- 230000003321 amplification Effects 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 238000003199 nucleic acid amplification method Methods 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- OLVCTPPSXNRGKV-GUBZILKMSA-N Ala-Pro-Pro Chemical compound C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(O)=O)CCC1 OLVCTPPSXNRGKV-GUBZILKMSA-N 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- 102100031780 Endonuclease Human genes 0.000 description 2
- JBCLFWXMTIKCCB-UHFFFAOYSA-N H-Gly-Phe-OH Natural products NCC(=O)NC(C(O)=O)CC1=CC=CC=C1 JBCLFWXMTIKCCB-UHFFFAOYSA-N 0.000 description 2
- SBANPBVRHYIMRR-UHFFFAOYSA-N Leu-Ser-Pro Natural products CC(C)CC(N)C(=O)NC(CO)C(=O)N1CCCC1C(O)=O SBANPBVRHYIMRR-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- 108010092854 aspartyllysine Proteins 0.000 description 2
- 239000012148 binding buffer Substances 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- XVZCXCTYGHPNEM-IHRRRGAJSA-N (2s)-1-[(2s)-2-[[(2s)-2-amino-4-methylpentanoyl]amino]-4-methylpentanoyl]pyrrolidine-2-carboxylic acid Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(O)=O XVZCXCTYGHPNEM-IHRRRGAJSA-N 0.000 description 1
- COEXAQSTZUWMRI-STQMWFEESA-N (2s)-1-[2-[[(2s)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]acetyl]pyrrolidine-2-carboxylic acid Chemical compound C([C@H](N)C(=O)NCC(=O)N1[C@@H](CCC1)C(O)=O)C1=CC=C(O)C=C1 COEXAQSTZUWMRI-STQMWFEESA-N 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- HHGYNJRJIINWAK-FXQIFTODSA-N Ala-Ala-Arg Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N HHGYNJRJIINWAK-FXQIFTODSA-N 0.000 description 1
- UCIYCBSJBQGDGM-LPEHRKFASA-N Ala-Arg-Pro Chemical compound C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@@H]1C(=O)O)N UCIYCBSJBQGDGM-LPEHRKFASA-N 0.000 description 1
- CVHJIWVKTFNGHT-ACZMJKKPSA-N Ala-Gln-Cys Chemical compound C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CS)C(=O)O)N CVHJIWVKTFNGHT-ACZMJKKPSA-N 0.000 description 1
- VWEWCZSUWOEEFM-WDSKDSINSA-N Ala-Gly-Ala-Gly Chemical compound C[C@H](N)C(=O)NCC(=O)N[C@@H](C)C(=O)NCC(O)=O VWEWCZSUWOEEFM-WDSKDSINSA-N 0.000 description 1
- NJWJSLCQEDMGNC-MBLNEYKQSA-N Ala-His-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@H](C)N)O NJWJSLCQEDMGNC-MBLNEYKQSA-N 0.000 description 1
- MEFILNJXAVSUTO-JXUBOQSCSA-N Ala-Leu-Thr Chemical compound C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O MEFILNJXAVSUTO-JXUBOQSCSA-N 0.000 description 1
- UWIQWPWWZUHBAO-ZLIFDBKOSA-N Ala-Leu-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@@H](NC(=O)[C@H](C)N)CC(C)C)C(O)=O)=CNC2=C1 UWIQWPWWZUHBAO-ZLIFDBKOSA-N 0.000 description 1
- YCRAFFCYWOUEOF-DLOVCJGASA-N Ala-Phe-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)C)CC1=CC=CC=C1 YCRAFFCYWOUEOF-DLOVCJGASA-N 0.000 description 1
- DCVYRWFAMZFSDA-ZLUOBGJFSA-N Ala-Ser-Ala Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O DCVYRWFAMZFSDA-ZLUOBGJFSA-N 0.000 description 1
- 235000010585 Ammi visnaga Nutrition 0.000 description 1
- 244000153158 Ammi visnaga Species 0.000 description 1
- GDVDRMUYICMNFJ-CIUDSAMLSA-N Arg-Cys-Glu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(O)=O)C(O)=O GDVDRMUYICMNFJ-CIUDSAMLSA-N 0.000 description 1
- HPSVTWMFWCHKFN-GARJFASQSA-N Arg-Glu-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCN=C(N)N)N)C(=O)O HPSVTWMFWCHKFN-GARJFASQSA-N 0.000 description 1
- OQCWXQJLCDPRHV-UWVGGRQHSA-N Arg-Gly-Leu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC(C)C)C(O)=O OQCWXQJLCDPRHV-UWVGGRQHSA-N 0.000 description 1
- SUMJNGAMIQSNGX-TUAOUCFPSA-N Arg-Val-Pro Chemical compound CC(C)[C@H](NC(=O)[C@@H](N)CCCNC(N)=N)C(=O)N1CCC[C@@H]1C(O)=O SUMJNGAMIQSNGX-TUAOUCFPSA-N 0.000 description 1
- VWJFQGXPYOPXJH-ZLUOBGJFSA-N Asn-Cys-Asp Chemical compound C([C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(=O)O)C(=O)O)N)C(=O)N VWJFQGXPYOPXJH-ZLUOBGJFSA-N 0.000 description 1
- FTCGGKNCJZOPNB-WHFBIAKZSA-N Asn-Gly-Ser Chemical compound NC(=O)C[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O FTCGGKNCJZOPNB-WHFBIAKZSA-N 0.000 description 1
- ICZWAZVKLACMKR-CIUDSAMLSA-N Asp-His-Ser Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CO)C(O)=O)CC1=CN=CN1 ICZWAZVKLACMKR-CIUDSAMLSA-N 0.000 description 1
- CJUKAWUWBZCTDQ-SRVKXCTJSA-N Asp-Leu-Lys Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(O)=O CJUKAWUWBZCTDQ-SRVKXCTJSA-N 0.000 description 1
- VNXQRBXEQXLERQ-CIUDSAMLSA-N Asp-Ser-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)N VNXQRBXEQXLERQ-CIUDSAMLSA-N 0.000 description 1
- JSNWZMFSLIWAHS-HJGDQZAQSA-N Asp-Thr-Leu Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)[C@H](CC(=O)O)N)O JSNWZMFSLIWAHS-HJGDQZAQSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- PLBJMUUEGBBHRH-ZLUOBGJFSA-N Cys-Ala-Asn Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(O)=O PLBJMUUEGBBHRH-ZLUOBGJFSA-N 0.000 description 1
- UKVGHFORADMBEN-GUBZILKMSA-N Cys-Arg-Arg Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O UKVGHFORADMBEN-GUBZILKMSA-N 0.000 description 1
- QLCPDGRAEJSYQM-LPEHRKFASA-N Cys-Arg-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CS)N)C(=O)O QLCPDGRAEJSYQM-LPEHRKFASA-N 0.000 description 1
- ZIKWRNJXFIQECJ-CIUDSAMLSA-N Cys-Cys-Leu Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(O)=O ZIKWRNJXFIQECJ-CIUDSAMLSA-N 0.000 description 1
- XTHUKRLJRUVVBF-WHFBIAKZSA-N Cys-Gly-Ser Chemical compound SC[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O XTHUKRLJRUVVBF-WHFBIAKZSA-N 0.000 description 1
- JLZCAZJGWNRXCI-XKBZYTNZSA-N Cys-Thr-Glu Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(O)=O JLZCAZJGWNRXCI-XKBZYTNZSA-N 0.000 description 1
- DGQJGBDBFVGLGL-ZKWXMUAHSA-N Cys-Val-Asp Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CS)N DGQJGBDBFVGLGL-ZKWXMUAHSA-N 0.000 description 1
- 230000004544 DNA amplification Effects 0.000 description 1
- 108010042407 Endonucleases Proteins 0.000 description 1
- KVYVOGYEMPEXBT-GUBZILKMSA-N Gln-Ala-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCC(N)=O KVYVOGYEMPEXBT-GUBZILKMSA-N 0.000 description 1
- MQANCSUBSBJNLU-KKUMJFAQSA-N Gln-Arg-Tyr Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O MQANCSUBSBJNLU-KKUMJFAQSA-N 0.000 description 1
- WBYHRQBKJGEBQJ-CIUDSAMLSA-N Gln-Pro-Cys Chemical compound C1C[C@H](N(C1)C(=O)[C@H](CCC(=O)N)N)C(=O)N[C@@H](CS)C(=O)O WBYHRQBKJGEBQJ-CIUDSAMLSA-N 0.000 description 1
- WLRYGVYQFXRJDA-DCAQKATOSA-N Gln-Pro-Pro Chemical compound NC(=O)CC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(O)=O)CCC1 WLRYGVYQFXRJDA-DCAQKATOSA-N 0.000 description 1
- JHSRJMUJOGLIHK-GUBZILKMSA-N Glu-Met-Glu Chemical compound CSCC[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CCC(=O)O)N JHSRJMUJOGLIHK-GUBZILKMSA-N 0.000 description 1
- DAHLWSFUXOHMIA-FXQIFTODSA-N Glu-Ser-Gln Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(O)=O DAHLWSFUXOHMIA-FXQIFTODSA-N 0.000 description 1
- GMVCSRBOSIUTFC-FXQIFTODSA-N Glu-Ser-Glu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(O)=O GMVCSRBOSIUTFC-FXQIFTODSA-N 0.000 description 1
- QOXDAWODGSIDDI-GUBZILKMSA-N Glu-Ser-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)N QOXDAWODGSIDDI-GUBZILKMSA-N 0.000 description 1
- QCMVGXDELYMZET-GLLZPBPUSA-N Glu-Thr-Glu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(O)=O QCMVGXDELYMZET-GLLZPBPUSA-N 0.000 description 1
- UGVQELHRNUDMAA-BYPYZUCNSA-N Gly-Ala-Gly Chemical compound [NH3+]CC(=O)N[C@@H](C)C(=O)NCC([O-])=O UGVQELHRNUDMAA-BYPYZUCNSA-N 0.000 description 1
- CEXINUGNTZFNRY-BYPYZUCNSA-N Gly-Cys-Gly Chemical compound [NH3+]CC(=O)N[C@@H](CS)C(=O)NCC([O-])=O CEXINUGNTZFNRY-BYPYZUCNSA-N 0.000 description 1
- FQKKPCWTZZEDIC-XPUUQOCRSA-N Gly-His-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)CN)CC1=CN=CN1 FQKKPCWTZZEDIC-XPUUQOCRSA-N 0.000 description 1
- NSTUFLGQJCOCDL-UWVGGRQHSA-N Gly-Leu-Arg Chemical compound NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N NSTUFLGQJCOCDL-UWVGGRQHSA-N 0.000 description 1
- OOCFXNOVSLSHAB-IUCAKERBSA-N Gly-Pro-Pro Chemical compound NCC(=O)N1CCC[C@H]1C(=O)N1[C@H](C(O)=O)CCC1 OOCFXNOVSLSHAB-IUCAKERBSA-N 0.000 description 1
- IZVICCORZOSGPT-JSGCOSHPSA-N Gly-Val-Tyr Chemical compound [H]NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O IZVICCORZOSGPT-JSGCOSHPSA-N 0.000 description 1
- KOPIAUWNLKKELG-SIGLWIIPSA-N Ile-His-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)O)N KOPIAUWNLKKELG-SIGLWIIPSA-N 0.000 description 1
- GVNNAHIRSDRIII-AJNGGQMLSA-N Ile-Lys-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)N GVNNAHIRSDRIII-AJNGGQMLSA-N 0.000 description 1
- UGTHTQWIQKEDEH-BQBZGAKWSA-N L-alanyl-L-prolylglycine zwitterion Chemical compound C[C@H](N)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O UGTHTQWIQKEDEH-BQBZGAKWSA-N 0.000 description 1
- 241000880493 Leptailurus serval Species 0.000 description 1
- HASRFYOMVPJRPU-SRVKXCTJSA-N Leu-Arg-Glu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(O)=O)C(O)=O HASRFYOMVPJRPU-SRVKXCTJSA-N 0.000 description 1
- ULXYQAJWJGLCNR-YUMQZZPRSA-N Leu-Asp-Gly Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(O)=O ULXYQAJWJGLCNR-YUMQZZPRSA-N 0.000 description 1
- PBGDOSARRIJMEV-DLOVCJGASA-N Leu-His-Ala Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](C)C(O)=O PBGDOSARRIJMEV-DLOVCJGASA-N 0.000 description 1
- DSFYPIUSAMSERP-IHRRRGAJSA-N Leu-Leu-Arg Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N DSFYPIUSAMSERP-IHRRRGAJSA-N 0.000 description 1
- XVZCXCTYGHPNEM-UHFFFAOYSA-N Leu-Leu-Pro Natural products CC(C)CC(N)C(=O)NC(CC(C)C)C(=O)N1CCCC1C(O)=O XVZCXCTYGHPNEM-UHFFFAOYSA-N 0.000 description 1
- SBANPBVRHYIMRR-GARJFASQSA-N Leu-Ser-Pro Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CO)C(=O)N1CCC[C@@H]1C(=O)O)N SBANPBVRHYIMRR-GARJFASQSA-N 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- GAOJCVKPIGHTGO-UWVGGRQHSA-N Lys-Arg-Gly Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(O)=O GAOJCVKPIGHTGO-UWVGGRQHSA-N 0.000 description 1
- NRQRKMYZONPCTM-CIUDSAMLSA-N Lys-Asp-Ser Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(O)=O NRQRKMYZONPCTM-CIUDSAMLSA-N 0.000 description 1
- GQZMPWBZQALKJO-UWVGGRQHSA-N Lys-Gly-Arg Chemical compound [H]N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(O)=O GQZMPWBZQALKJO-UWVGGRQHSA-N 0.000 description 1
- GPJGFSFYBJGYRX-YUMQZZPRSA-N Lys-Gly-Asp Chemical compound NCCCC[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CC(O)=O GPJGFSFYBJGYRX-YUMQZZPRSA-N 0.000 description 1
- PYFNONMJYNJENN-AVGNSLFASA-N Lys-Lys-Gln Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N PYFNONMJYNJENN-AVGNSLFASA-N 0.000 description 1
- YUAXTFMFMOIMAM-QWRGUYRKSA-N Lys-Lys-Gly Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCC(O)=O YUAXTFMFMOIMAM-QWRGUYRKSA-N 0.000 description 1
- GZGWILAQHOVXTD-DCAQKATOSA-N Lys-Met-Asp Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(O)=O GZGWILAQHOVXTD-DCAQKATOSA-N 0.000 description 1
- RQILLQOQXLZTCK-KBPBESRZSA-N Lys-Tyr-Gly Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)NCC(O)=O RQILLQOQXLZTCK-KBPBESRZSA-N 0.000 description 1
- QLFAPXUXEBAWEK-NHCYSSNCSA-N Lys-Val-Asp Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O QLFAPXUXEBAWEK-NHCYSSNCSA-N 0.000 description 1
- LRALLISKBZNSKN-BQBZGAKWSA-N Met-Gly-Ser Chemical compound CSCC[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O LRALLISKBZNSKN-BQBZGAKWSA-N 0.000 description 1
- PZUUMQPMHBJJKE-AVGNSLFASA-N Met-Leu-Arg Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CCCNC(N)=N PZUUMQPMHBJJKE-AVGNSLFASA-N 0.000 description 1
- YBAFDPFAUTYYRW-UHFFFAOYSA-N N-L-alpha-glutamyl-L-leucine Natural products CC(C)CC(C(O)=O)NC(=O)C(N)CCC(O)=O YBAFDPFAUTYYRW-UHFFFAOYSA-N 0.000 description 1
- KZNQNBZMBZJQJO-UHFFFAOYSA-N N-glycyl-L-proline Natural products NCC(=O)N1CCCC1C(O)=O KZNQNBZMBZJQJO-UHFFFAOYSA-N 0.000 description 1
- HNURHHFOINNTPL-IHPCNDPISA-N Phe-Cys-Trp Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC2=CNC3=CC=CC=C32)C(=O)O)N HNURHHFOINNTPL-IHPCNDPISA-N 0.000 description 1
- KBVJZCVLQWCJQN-KKUMJFAQSA-N Phe-Leu-Asn Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O KBVJZCVLQWCJQN-KKUMJFAQSA-N 0.000 description 1
- MCIXMYKSPQUMJG-SRVKXCTJSA-N Phe-Ser-Ser Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O MCIXMYKSPQUMJG-SRVKXCTJSA-N 0.000 description 1
- DBNGDEAQXGFGRA-ACRUOGEOSA-N Phe-Tyr-Lys Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)N[C@@H](CCCCN)C(=O)O)N DBNGDEAQXGFGRA-ACRUOGEOSA-N 0.000 description 1
- NHDVNAKDACFHPX-GUBZILKMSA-N Pro-Arg-Ala Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(O)=O NHDVNAKDACFHPX-GUBZILKMSA-N 0.000 description 1
- ICTZKEXYDDZZFP-SRVKXCTJSA-N Pro-Arg-Pro Chemical compound N([C@@H](CCCN=C(N)N)C(=O)N1[C@@H](CCC1)C(O)=O)C(=O)[C@@H]1CCCN1 ICTZKEXYDDZZFP-SRVKXCTJSA-N 0.000 description 1
- QXNSKJLSLYCTMT-FXQIFTODSA-N Pro-Cys-Asp Chemical compound C1C[C@H](NC1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(=O)O)C(=O)O QXNSKJLSLYCTMT-FXQIFTODSA-N 0.000 description 1
- ULIWFCCJIOEHMU-BQBZGAKWSA-N Pro-Gly-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H]1CCCN1 ULIWFCCJIOEHMU-BQBZGAKWSA-N 0.000 description 1
- MCWHYUWXVNRXFV-RWMBFGLXSA-N Pro-Leu-Pro Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@@H]2CCCN2 MCWHYUWXVNRXFV-RWMBFGLXSA-N 0.000 description 1
- SBVPYBFMIGDIDX-SRVKXCTJSA-N Pro-Pro-Pro Chemical compound OC(=O)[C@@H]1CCCN1C(=O)[C@H]1N(C(=O)[C@H]2NCCC2)CCC1 SBVPYBFMIGDIDX-SRVKXCTJSA-N 0.000 description 1
- GZNYIXWOIUFLGO-ZJDVBMNYSA-N Pro-Thr-Thr Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O GZNYIXWOIUFLGO-ZJDVBMNYSA-N 0.000 description 1
- FHJQROWZEJFZPO-SRVKXCTJSA-N Pro-Val-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]1CCCN1 FHJQROWZEJFZPO-SRVKXCTJSA-N 0.000 description 1
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
- CICQXRWZNVXFCU-SRVKXCTJSA-N Ser-His-Leu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(C)C)C(O)=O CICQXRWZNVXFCU-SRVKXCTJSA-N 0.000 description 1
- DINQYZRMXGWWTG-GUBZILKMSA-N Ser-Pro-Pro Chemical compound OC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(O)=O)CCC1 DINQYZRMXGWWTG-GUBZILKMSA-N 0.000 description 1
- WUXCHQZLUHBSDJ-LKXGYXEUSA-N Ser-Thr-Asp Chemical compound OC[C@H](N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CC(O)=O)C(O)=O WUXCHQZLUHBSDJ-LKXGYXEUSA-N 0.000 description 1
- KKKVOZNCLALMPV-XKBZYTNZSA-N Ser-Thr-Glu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(O)=O KKKVOZNCLALMPV-XKBZYTNZSA-N 0.000 description 1
- QWMPARMKIDVBLV-VZFHVOOUSA-N Thr-Cys-Ala Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(O)=O QWMPARMKIDVBLV-VZFHVOOUSA-N 0.000 description 1
- GCXFWAZRHBRYEM-NUMRIWBASA-N Thr-Gln-Asn Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)O)N)O GCXFWAZRHBRYEM-NUMRIWBASA-N 0.000 description 1
- FHDLKMFZKRUQCE-HJGDQZAQSA-N Thr-Glu-Arg Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O FHDLKMFZKRUQCE-HJGDQZAQSA-N 0.000 description 1
- CQNFRKAKGDSJFR-NUMRIWBASA-N Thr-Glu-Asn Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)N)C(=O)O)N)O CQNFRKAKGDSJFR-NUMRIWBASA-N 0.000 description 1
- YOOAQCZYZHGUAZ-KATARQTJSA-N Thr-Leu-Ser Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O YOOAQCZYZHGUAZ-KATARQTJSA-N 0.000 description 1
- JTWIMNMUYLQNPI-WPRPVWTQSA-N Val-Gly-Arg Chemical compound CC(C)[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCCNC(N)=N JTWIMNMUYLQNPI-WPRPVWTQSA-N 0.000 description 1
- MANXHLOVEUHVFD-DCAQKATOSA-N Val-His-Cys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CS)C(=O)O)N MANXHLOVEUHVFD-DCAQKATOSA-N 0.000 description 1
- DIOSYUIWOQCXNR-ONGXEEELSA-N Val-Lys-Gly Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)NCC(O)=O DIOSYUIWOQCXNR-ONGXEEELSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 108010069020 alanyl-prolyl-glycine Proteins 0.000 description 1
- KOSRFJWDECSPRO-UHFFFAOYSA-N alpha-L-glutamyl-L-glutamic acid Natural products OC(=O)CCC(N)C(=O)NC(CCC(O)=O)C(O)=O KOSRFJWDECSPRO-UHFFFAOYSA-N 0.000 description 1
- 150000001413 amino acids Chemical group 0.000 description 1
- 108010062796 arginyllysine Proteins 0.000 description 1
- 108010093581 aspartyl-proline Proteins 0.000 description 1
- 108010068265 aspartyltyrosine Proteins 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 238000012411 cloning technique Methods 0.000 description 1
- 108010016616 cysteinylglycine Proteins 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000012149 elution buffer Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 108010063718 gamma-glutamylaspartic acid Proteins 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 108010055341 glutamyl-glutamic acid Proteins 0.000 description 1
- 108010010147 glycylglutamine Proteins 0.000 description 1
- 108010015792 glycyllysine Proteins 0.000 description 1
- 108010081551 glycylphenylalanine Proteins 0.000 description 1
- 108010077515 glycylproline Proteins 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 108010057821 leucylproline Proteins 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 238000003752 polymerase chain reaction Methods 0.000 description 1
- 238000012257 pre-denaturation Methods 0.000 description 1
- 108010077112 prolyl-proline Proteins 0.000 description 1
- 108010029020 prolylglycine Proteins 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000026267 regulation of growth Effects 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 238000003757 reverse transcription PCR Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 238000003307 slaughter Methods 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 108010051110 tyrosyl-lysine Proteins 0.000 description 1
- IBIDRSSEHFLGSD-UHFFFAOYSA-N valinyl-arginine Natural products CC(C)C(N)C(=O)NC(C(O)=O)CCCN=C(N)N IBIDRSSEHFLGSD-UHFFFAOYSA-N 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
本发明公开了一种山羊IGFBP3基因cDNA编码序列克隆的方法,其核苷酸序列如序列表SEQ ID NO:1所示,包括以下步骤:A1、提取山羊背最长肌组织中的总RNA,然后将总RNA反转录成cDNA;A2、引物的设计和PCR扩增:以绵羊该基因的序列为模板在起始密码子上游区域和终止密码子的下游区域设计引物,设计的引物为:正向引物:5'AGCTCGCTGCCGCCCAGT3',反向引物:5'GCTGATCATGTCCTTGGCAG3';A3、PCR产物的纯化回收;A4、克隆。本发明提供了一种简捷的获取山羊IGFBP3基因cDNA编码序列的方法,为进一步研究该基因在山羊生长发育过程的作用奠定了基础。The invention discloses a method for cloning the cDNA coding sequence of goat IGFBP3 gene, the nucleotide sequence of which is shown in the sequence table SEQ ID NO: 1, comprising the following steps: A1, extracting the total RNA in goat longissimus dorsi tissue, Then reverse-transcribe the total RNA into cDNA; A2, primer design and PCR amplification: use the sequence of the sheep gene as a template to design primers in the upstream region of the start codon and the downstream region of the stop codon, and the designed primers are: Forward primer: 5'AGCTCGCTGCCGCCCAGT3', reverse primer: 5'GCTGATCATGTCCTTGGCAG3'; A3, purification and recovery of PCR products; A4, cloning. The invention provides a simple method for obtaining the cDNA coding sequence of goat IGFBP3 gene, which lays a foundation for further research on the function of the gene in the growth and development process of goats.
Description
技术领域 technical field
本发明涉及动物基因工程技术领域,更具体地说涉及一种从山羊肌肉组织中克隆IGFBP3(Insulin-like growth factor binding protein 3)基因cDNA编码区序列的方法。 The invention relates to the technical field of animal genetic engineering, more specifically to a method for cloning the cDNA coding region sequence of IGFBP3 (Insulin-like growth factor binding protein 3) gene from goat muscle tissue.
背景技术 Background technique
胰岛素样生长因子结合蛋白(IGFBPs)作为胰岛素样生长因子系统的一员,其与胰岛素样生长因子(IGFs)之间是一个复杂的生长调节轴:IGFBPs与IGFs和酸敏感亚单元(ALS)结合形成三元复合物来运载IGFs,而且通过IGFBPs不同的亲和力与IGFs结合以调节游离IGFs的生物学活性,IGFBP-3是血液中浓度最高的胰岛素样生长因子结合蛋白,同时也是血清IGFs的主要载体,IGFBP-3主要和IGF-Ⅰ结合,有助于维持IGF-I的生物利用度,保证IGF-I的生物功效。因此IGFBP3基因在动物的生长、发育和代谢过程中起着重要的作用。 As a member of the insulin-like growth factor system, insulin-like growth factor-binding proteins (IGFBPs) and insulin-like growth factors (IGFs) are a complex growth regulation axis: IGFBPs bind to IGFs and acid-sensitive subunits (ALS) Form a ternary complex to carry IGFs, and bind to IGFs through different affinities of IGFBPs to regulate the biological activity of free IGFs. IGFBP-3 is the insulin-like growth factor binding protein with the highest concentration in blood, and it is also the main carrier of serum IGFs , IGFBP-3 is mainly combined with IGF-I, which helps to maintain the bioavailability of IGF-I and ensure the biological efficacy of IGF-I. Therefore, the IGFBP3 gene plays an important role in the growth, development and metabolism of animals.
RT-PCR克隆:是将RNA的反转录(RT)和cDNA的聚合酶链式反应以及分子克隆相结合的一种技术。首先利用反转录酶将RNA反转录成cDNA,再以cDNA为模板,扩增我们需要的目的基因片段,然后将此片段与载体连接转化到感受态细胞中进行克隆,获得的质粒PCR产物进行测序。此技术利用PCR 技术能在体外进行有效的基因扩增,而不需要内切酶消化和连接酶处理,能够快速获得其它依靠限制性内切酶消化法难于得到的PCR产物;同时该方法能克服普通PCR产物测序引物近端的十几个碱基无法测序获得的缺点。与RACE(cDNA末端快速扩增) 技术相比较而言,目的基因片段的长度明确,成本较低,工作量小。该技术的关键是PCR引物的设计,在起始密码子的上游设计正向引物,在终止密码子的下游设计反向引物,使得PCR产物能包含完整的基因编码区全序列。 RT-PCR cloning: It is a technology that combines RNA reverse transcription (RT) with cDNA polymerase chain reaction and molecular cloning. First, use reverse transcriptase to reverse transcribe RNA into cDNA, then use cDNA as a template to amplify the target gene fragment we need, and then connect this fragment with the vector and transform it into competent cells for cloning, and obtain the plasmid PCR product Perform sequencing. This technology utilizes PCR technology to carry out effective gene amplification in vitro without endonuclease digestion and ligase treatment, and can quickly obtain other PCR products that are difficult to obtain by restriction endonuclease digestion; at the same time, this method can overcome Common PCR product sequencing primer proximal more than a dozen bases can not be sequenced to obtain the disadvantage. Compared with RACE (rapid amplification of cDNA ends) technology, the length of the target gene fragment is clear, the cost is low, and the workload is small. The key to this technology is the design of PCR primers. A forward primer is designed upstream of the start codon, and a reverse primer is designed downstream of the stop codon, so that the PCR product can contain the entire sequence of the complete gene coding region.
分段PCR克隆法:将目的基因分成几个片段来分别克隆,然后再通过亚克隆测序将其拼接起来,此方法成本较高,耗时多且工作量大,一个基因分成几段就需要做几次克隆,然后再进行序列拼接。 Segmented PCR cloning method: the target gene is divided into several fragments to be cloned separately, and then spliced together by subcloning and sequencing. Cloning several times, followed by sequence assembly.
获得目的基因编码区序列一般采用克隆或RACE技术,RACE技术是基于PCR技术基础上由已知的一段cDNA片段,通过向两端延伸扩增从而获得完整的3’端和5’端。但该技术与克隆技术相比,目的基因片段的长度不明确,试验成本高,工作量大,对于提取的RNA质量要求较高,因此应用相对较少。 Cloning or RACE technology is generally used to obtain the coding region sequence of the target gene. RACE technology is based on PCR technology to obtain a complete 3' end and 5' end by extending and amplifying a known cDNA fragment to both ends. However, compared with the cloning technique, the length of the target gene fragment is not clear, the test cost is high, the workload is heavy, and the requirements for the quality of the extracted RNA are relatively high, so the application is relatively seldom.
发明内容 Contents of the invention
本发明所要解决的技术问题是针对现有技术的不足提供一种山羊IGFBP3基因cDNA编码序列克隆的方法。填补在山羊上该基因研究的空白,为进一步研究其在山羊上的功能奠定基础。 The technical problem to be solved by the present invention is to provide a method for cloning the cDNA coding sequence of goat IGFBP3 gene in view of the deficiencies in the prior art. To fill in the gaps in the study of this gene in goats and to lay the foundation for further research on its function in goats.
本发明采用以下技术方案: The present invention adopts following technical scheme:
山羊IGFBP3基因cDNA编码序列克隆的方法,包括以下步骤: The method for cloning the cDNA coding sequence of goat IGFBP3 gene comprises the following steps:
A1、从山羊背最长肌组织中提取总RNA,然后将总RNA反转录成cDNA; A1, total RNA was extracted from goat longissimus dorsi tissue, and then the total RNA was reverse-transcribed into cDNA;
A2:以绵羊该基因的序列为模板在起始密码子上游区域和终止密码子的下游区域设计引物; A2: Use the sequence of the sheep gene as a template to design primers in the upstream region of the start codon and the downstream region of the stop codon;
A3:以cDNA为模板进行PCR扩增; A3: PCR amplification using cDNA as template;
A4:扩增产物的胶回收和纯化; A4: Gel recovery and purification of amplification products;
A5:纯化的产物进行克隆与测序,即能得到山羊IGFBP3基因cDNA编码序列。 A5: The purified product is cloned and sequenced, and the cDNA coding sequence of the goat IGFBP3 gene can be obtained.
所述的方法,步骤A1包括以下步骤:取用液氮研磨好的组织粉末约80mg,加入预先盛有1mL Trizol的EP管中,振荡混匀后,室温静置5min;加氯仿0.2mL(必须按总体积的1/5),旋涡仪振荡混匀15s,室温静置5min;4℃下12000rpm离心15min;转移上层水相450μL于另一个新的1.5mLEP管中,加入等体积异丙醇,颠倒混匀后室温静置10min;4℃下12000rpm离心10min;弃去上层清液后,加入4℃预冷的75%乙醇(用DEPC处理水配制)1mL,静置5min,4℃下7500g离心5min;弃上清,用枪吸取多余的液体,空气干燥约3min;加入30μL DEPC处理水,吹打混匀,充分溶解RNA,然后立即反转录成cDNA。 The method, step A1 includes the following steps: take about 80 mg of tissue powder ground with liquid nitrogen, add it to an EP tube filled with 1 mL Trizol in advance, shake and mix well, and let stand at room temperature for 5 minutes; add 0.2 mL of chloroform (must According to 1/5 of the total volume), vortex for 15 seconds, and let stand at room temperature for 5 minutes; centrifuge at 12,000 rpm for 15 minutes at 4°C; transfer 450 μL of the upper aqueous phase to another new 1.5mLEP tube, add an equal volume of isopropanol, After inverting and mixing, let stand at room temperature for 10 minutes; centrifuge at 12,000 rpm at 4°C for 10 minutes; discard the supernatant, add 1 mL of 75% ethanol (prepared with DEPC-treated water) pre-cooled at 4°C, let stand for 5 minutes, and centrifuge at 7,500 g at 4°C 5min; Discard the supernatant, suck up the excess liquid with a gun, and air dry for about 3min; add 30μL of DEPC-treated water, mix well by pipetting, fully dissolve the RNA, and then immediately reverse transcribe into cDNA.
所述的方法,步骤A2中引物为SEQ ID NO:3和SEQ ID NO:4。 In the method, the primers in step A2 are SEQ ID NO: 3 and SEQ ID NO: 4.
附图说明 Description of drawings
图1是山羊IGFBP3基因的PCR产物电泳图。 Fig. 1 is the electrophoresis diagram of the PCR product of goat IGFBP3 gene.
图2是山羊IGFBP3基因编码区的核苷酸序列和对应的氨基酸序列。 Fig. 2 is the nucleotide sequence and corresponding amino acid sequence of the goat IGFBP3 gene coding region.
具体实施方式 Detailed ways
以下结合具体实施例,对本发明进行详细说明。 The present invention will be described in detail below in conjunction with specific embodiments.
具体实施步骤: Specific implementation steps:
1、组织样的采集 1. Collection of tissue samples
选取出生后120d的南江黄羊进行宰杀,取其背最长肌组织样品后迅速置于液氮中保存待用。 Nanjiang yellow sheep at 120 days after birth were selected for slaughter, and longissimus dorsi tissue samples were taken and immediately stored in liquid nitrogen for later use.
2、总RNA的提取和cDNA的合成 2. Extraction of total RNA and synthesis of cDNA
(1) 取用液氮研磨好的组织粉末80mg,加入预先盛有1mL Trizol的EP管中,振荡混匀后,室温静置5min; (1) Take 80 mg of tissue powder ground with liquid nitrogen, add it to the EP tube filled with 1 mL Trizol in advance, shake and mix, and let stand at room temperature for 5 minutes;
(2) 加氯仿0.2mL(必须按总体积的1/5),旋涡仪振荡混匀15秒,室温静置5min;(3)4℃下12000rpm离心15min; (2) Add 0.2 mL of chloroform (must be 1/5 of the total volume), vortex for 15 seconds, and let stand at room temperature for 5 minutes; (3) Centrifuge at 12,000 rpm for 15 minutes at 4°C;
(4)转移上层水相450μL于另一个新的1.5mLEP管中,加入等体积异丙醇,颠倒混匀后室温静置10min; (4) Transfer 450 μL of the upper aqueous phase to another new 1.5mLEP tube, add an equal volume of isopropanol, invert and mix well, and let stand at room temperature for 10 minutes;
(5)4℃下12000rpm离心10min; (5) Centrifuge at 12,000 rpm for 10 minutes at 4°C;
(6)弃去上层清液后,加入4℃预冷的75%乙醇(用DEPC处理水配制)1mL,静置5min, (6) After discarding the supernatant, add 1 mL of 75% ethanol (prepared with DEPC-treated water) pre-cooled at 4°C, and let it stand for 5 minutes.
(7)4℃下7500g离心5min; (7) Centrifuge at 7500g for 5min at 4°C;
(8)弃上清,用枪吸取多余的液体,空气干燥约3min;加入30μL DEPC处理水,吹打混匀,充分溶解RNA。 (8) Discard the supernatant, suck up the excess liquid with a gun, and air dry for about 3 minutes; add 30 μL of DEPC-treated water, mix well by pipetting, and fully dissolve the RNA.
(9)用1%的琼脂糖凝胶电泳法检测总RNA的质量,效果好的立即反转录成cDNA。 (9) Use 1% agarose gel electrophoresis to detect the quality of the total RNA, and immediately reverse-transcribe it into cDNA if the effect is good.
3、目的基因片段的扩增 3. Amplification of target gene fragments
(1)引物的设计:根据GenBank数据库中公布的绵羊(Ovis aries)的IGFBP3(NM_001134302)基因序列,采用Primer Premier 5.0软件设计引物,设计的引物为: (1) Primer design: According to the IGFBP3 (NM_001134302) gene sequence of sheep ( Ovis aries ) published in the GenBank database, primers were designed using Primer Premier 5.0 software. The designed primers were:
正向引物:5' AGCTCGCTGCCGCCCAGT 3' Forward primer: 5' AGCTCGCTGCCGCCCAGT 3'
反向引物:5' GCTGATCATGTCCTTGGCAG 3' Reverse primer: 5' GCTGATCATGTCCTTGGCAG 3'
(2) PCR的反应体系和条件:反应体系(25μL):0.25 μL的TaKaRa Taq酶,12.5 μL的 2×GC Buffer I,4 μL的dNTP Mixture,正反向引物各0.5 μL,6.25 μL的灭菌ddH2O,模板cDNA 1 μL。反应条件为95℃预变性4 min,35个循环(94℃,45 s;53.4℃,30 s;72℃,90 s),最后72℃ 7 min;PCR产物用1.5%的琼脂糖凝胶进行电泳检测。 (2) PCR reaction system and conditions: Reaction system (25 μL): 0.25 μL of TaKaRa Taq enzyme, 12.5 μL of 2×GC Buffer I, 4 μL of dNTP Mixture, 0.5 μL of forward and reverse primers, 6.25 μL of bacteria ddH 2 O, template cDNA 1 μL. The reaction conditions were pre-denaturation at 95°C for 4 min, 35 cycles (94°C, 45 s; 53.4°C, 30 s; 72°C, 90 s), and finally 72°C for 7 min; PCR products were analyzed with 1.5% agarose gel Electrophoretic detection.
4、PCR产物的回收和纯化 4. Recovery and purification of PCR products
PCR产物用上海生工UNIQ-10柱式DNA胶回收试剂盒纯化回收,具体步骤为: The PCR product was purified and recovered with Shanghai Sangon UNIQ-10 Column DNA Gel Recovery Kit. The specific steps are as follows:
(1)通过1.5%的琼脂糖凝胶电泳将目的DNA片段与其它DNA尽可能分开,然后用干净的手术刀将含有目的DNA片段的琼脂糖凝胶块切下,放入1.5 mL离心管中。 (1) Separate the target DNA fragment from other DNA as much as possible by 1.5% agarose gel electrophoresis, then cut off the agarose gel block containing the target DNA fragment with a clean scalpel, and put it into a 1.5 mL centrifuge tube .
(2)称量凝胶的重量,根据胶块的重量和浓度,按每100mg琼脂糖加400μL的比例加入Binding Buffer Ⅱ。 (2) Weigh the weight of the gel, and add Binding Buffer II at a ratio of 400 μL per 100 mg of agarose according to the weight and concentration of the gel.
(3)将离心管置于55 ℃金属恒温浴中5~10 min,间或混匀,直至胶块完全溶化。 (3) Place the centrifuge tube in a metal constant temperature bath at 55°C for 5-10 minutes, and mix it occasionally until the glue block is completely melted.
(4)(可选步骤)当目的片段<500bp时,加入所使用的Binding Buffer Ⅱ 1/3 体积的异丙醇混匀。当目的片段>500bp时,此步骤可以省略,直接进行步骤(5)。 (4) (Optional step) When the target fragment is <500bp, add 1/3 volume of isopropanol of the Binding Buffer II used and mix well. When the target fragment is >500bp, this step can be omitted, and step (5) can be performed directly.
(5)将溶化的胶溶液转移到套放在2ml收集管内的UNIQ-10柱中,室温放置2 min。8000 rpm室温离心1 min。 (5) Transfer the melted gel solution to a UNIQ-10 column set in a 2ml collection tube, and place at room temperature for 2 minutes. Centrifuge at 8000 rpm for 1 min at room temperature.
(6)取下UNIQ-10柱,倒掉收集管中的废液,将UNIQ-10柱放入同一个收集管中,加入500 μL Wash Solution,10000 rpm室温离心1 min。 (6) Remove the UNIQ-10 column, discard the waste liquid in the collection tube, put the UNIQ-10 column into the same collection tube, add 500 μL Wash Solution, and centrifuge at 10,000 rpm for 1 min at room temperature.
(7)重复步骤(6)一次。 (7) Repeat step (6) once.
(8)取下UNIQ-10柱,倒掉收集管中的废液,将UNIQ-10柱放入同一个收集管中,12000 rpm室温离心2 min。 (8) Remove the UNIQ-10 column, discard the waste liquid in the collection tube, put the UNIQ-10 column into the same collection tube, and centrifuge at 12000 rpm for 2 min at room temperature.
(9)将UNIQ-10柱放入一新的1.5 mL离心管中,在吸附膜中央加30 μL Elution Buffer,室温放置1~2 min。12000 rpm室温离心1 min,离心管中的液体即为回收的DNA片段。 (9) Put the UNIQ-10 column into a new 1.5 mL centrifuge tube, add 30 μL Elution Buffer to the center of the adsorption membrane, and place it at room temperature for 1~2 min. Centrifuge at room temperature at 12000 rpm for 1 min, and the liquid in the centrifuge tube is the recovered DNA fragment.
(10)取收集的DNA 2μL,1.5%琼脂糖凝胶电泳,检测回收的DNA质量。 (10) Take 2 μL of the collected DNA, electrophoresis on 1.5% agarose gel, and check the quality of the recovered DNA.
4、产物的克隆 4. Cloning of the product
(1)目的片段与载体连接 (1) The target fragment is connected to the carrier
将胶回收产物与pMD19-T载体连接。将载体在冰上融化,短暂离心装有载体的离心管,以免液体挂在管壁上。在超净操作台上按照如下体系配置连接液: The gel recovered product was ligated with pMD19-T vector. Thaw the carrier on ice and centrifuge the tube containing the carrier briefly to avoid hanging the liquid on the tube wall. Configure the connecting liquid on the ultra-clean operating table according to the following system:
将反应混合液置于16℃水浴锅中连接3h。 Place the reaction mixture in a water bath at 16°C for 3 hours.
(2)连接产物的转化 (2) Conversion of ligated products
从-80℃冰箱取出保存的感受态细胞DH5α冰浴助融,吸取50μL加入到10μL连接液中,轻轻旋转混匀。 Take out the preserved DH5α competent cells from the -80°C refrigerator to help thaw in an ice bath, pipette 50 μL into 10 μL of the connection solution, and swirl gently to mix well.
冰上放置30min。 Place on ice for 30min.
热激转化:42℃加热45 s后,放在冰上1~2min。 Heat shock transformation: heat at 42°C for 45 s, then place on ice for 1-2 min.
加入预先保存在37℃的LB培养基800μL于37℃振摇培养45min。 Add 800 μL of LB medium pre-stored at 37°C and shake at 37°C for 45 minutes.
室温下4000g离心10min,吸掉上清液600μL。 Centrifuge at 4000 g for 10 min at room temperature, and suck off 600 μL of the supernatant.
吸取连接产物到平板上均匀涂布,液体被完全吸收后倒置于37℃的培养箱中培养12~16 h。 Pipette the ligation product onto the plate and evenly spread it on the plate. After the liquid is completely absorbed, place it upside down in an incubator at 37°C for 12-16 h.
(3)阳性克隆的筛选 (3) Screening of positive clones
用灭过菌的牙签挑取单个菌落,接种于含有Amp的800μL LB培养基中,37 ℃,200r/min振荡培养5 h后吸取1 μL菌液作PCR模板,依据PCR扩增的体系和条件进行PCR鉴定,产物通过1.5%琼脂糖凝胶电泳来检测。依据菌液PCR检测结果,吸取含有阳性克隆的菌液800μL,送往上海生工生物工程有限公司进行测序。 Pick a single colony with a sterilized toothpick, inoculate it in 800 μL LB medium containing Amp, incubate at 37 °C and 200 r/min for 5 h, then draw 1 μL of the bacterial solution as a PCR template, according to the PCR amplification system and conditions PCR identification was carried out, and the products were detected by 1.5% agarose gel electrophoresis. According to the results of bacterial liquid PCR detection, 800 μL of bacterial liquid containing positive clones was drawn and sent to Shanghai Sangon Bioengineering Co., Ltd. for sequencing.
5、序列的验证 5. Sequence verification
将测序结果使用DNAstar软件进行校队拼接,寻找基因的起始密码子与终止密码子,得到的IGFBP3基因882bp的完整编码区序列,通过与牛和绵羊的序列进行比对,所得山羊IGFBP3基因编码区序列与牛和绵羊的一致性分别为94.33%和99.09%。表明该方法能达到获得山羊IGFBP3基因的完整编码区序列的目的。提交该序列到GenBank数据库,获得的登录号为JQ341161。 The sequencing results were spliced using DNAstar software to find the start codon and stop codon of the gene, and the complete coding region sequence of 882bp of the IGFBP3 gene was obtained, and compared with the sequences of cattle and sheep, the obtained goat IGFBP3 gene code The identities of the region sequences with cattle and sheep were 94.33% and 99.09%, respectively. It shows that this method can achieve the goal of obtaining the complete coding region sequence of goat IGFBP3 gene. The sequence was submitted to the GenBank database, and the accession number obtained was JQ341161.
应当理解的是,对本领域普通技术人员来说,可以根据上述说明加以改进或变换,而所有这些改进和变换都应属于本发明所附权利要求的保护范围。 It should be understood that those skilled in the art can make improvements or changes based on the above description, and all these improvements and changes should belong to the protection scope of the appended claims of the present invention.
序列表sequence listing
SEQUENCE LISTING SEQUENCE LISTING
the
<110> 四川农业大学 <110> Sichuan Agricultural University
the
<120> 山羊IGFBP3基因cDNA编码序列克隆的方法 <120> Method for cloning goat IGFBP3 gene cDNA coding sequence
the
<130> 2013 <130> 2013
the
<160> 4 <160> 4
the
<170> PatentIn version 3.5 <170> PatentIn version 3.5
the
<210> 1 <210> 1
<211> 882 <211> 882
<212> DNA <212> DNA
<213> 山羊 <213> goat
the
<400> 1 <400> 1
atgctgcggg cacgccccgc gctctgggct gcggctctga ccgcgctggc attgctccgc 60 atgctgcggg cacgccccgc gctctgggct gcggctctga ccgcgctggc attgctccgc 60
the
ggaccgccgg cggcacgagc tggggcgggc acggcgggcg ccggcccggt ggtgcgctgc 120 ggaccgccgg cggcacgagc tggggcgggc acggcgggcg ccggcccggt ggtgcgctgc 120
the
gagccgtgcg acgcgcgtgc cgttgcccag tgcgcgccgc cgcccccctc gcccccgtgc 180 gagccgtgcg acgcgcgtgc cgttgcccag tgcgcgccgc cgcccccctc gcccccgtgc 180
the
accgagttgg tgcgcgagcc gggctgcggt tgctgtctca cttgcgcgct gcgcgagggt 240 accgagttgg tgcgcgagcc gggctgcggt tgctgtctca cttgcgcgct gcgcgagggt 240
the
cagccttgcg gcgtctacac cgagcgctgt ggctccggcc tccgctgcca gccgccgcct 300 cagccttgcg gcgtctacac cgagcgctgt ggctccggcc tccgctgcca gccgccgcct 300
the
ggcgatccgc gcccgctaca cgcgttgttg gacggccgcg ggctctgcgc caacgccagc 360 ggcgatccgc gcccgctaca cgcgttgttg gacggccgcg ggctctgcgc caacgccagc 360
the
gccgtcggcc gcctgagccc ctacctgctg cccgcgccac ccgcgccagg aaatggcagt 420 gccgtcggcc gcctgagccc ctacctgctg cccgcgccac ccgcgccagg aaatggcagt 420
the
gagtcggaag aagaccacag catggggagc acggagaacc aggctctccc caccacacgc 480 gagtcggaag aagaccacag catggggagc acggagaacc aggctctccc caccacacgc 480
the
cgggtgcccg actccaaatc ccacctcgcc cacaccaaga tggatgtcat caaaaaaggt 540 cgggtgcccg actccaaatc ccacctcgcc cacaccaaga tggatgtcat caaaaaaggt 540
the
catgccaagg acagccagcg ctacaaggtt gactacgagt ctcagagcac agacacccag 600 catgccaagg acagccagcg ctacaaggtt gactacgagt ctcagagcac agacacccag 600
the
aacttctcct ccgagtccaa gcatgagaca gaatacgggc cctgccgccg ggaaatggag 660 aacttctcct ccgagtccaa gcatgagaca gaatacgggc cctgccgccg ggaaatggag 660
the
gacacactga acgacctcaa gttcctgaac acactcagcc ccagggccat ccacattccc 720 gacacactga acgacctcaa gttcctgaac acactcagcc ccagggccat ccacattccc 720
the
aactgtgaca agaagggctt ctacaagaaa aagcagtgcc gcccttccaa gggcaggaag 780 aactgtgaca agaagggctt ctacaagaaa aagcagtgcc gcccttccaa gggcaggaag 780
the
cggggtttct gctggtgtgt ggataagtac gggcagcccc tcccggcctt cagcgtgaag 840 cggggtttct gctggtgtgt ggataagtac gggcagcccc tcccggcctt cagcgtgaag 840
the
gggaaagggg acgtgcactg cctcagcacg gagagcaagt ag 882 gggaaagggg acgtgcactg cctcagcacg gagagcaagt ag 882
the
the
<210> 2 <210> 2
<211> 293 <211> 293
<212> PRT <212> PRT
<213> 山羊 <213> goat
the
<400> 2 <400> 2
the
Met Leu Arg Ala Arg Pro Ala Leu Trp Ala Ala Ala Leu Thr Ala Leu Met Leu Arg Ala Arg Pro Ala Leu Trp Ala Ala Ala Leu Thr Ala Leu
1 5 10 15 1 5 10 15
the
the
Ala Leu Leu Arg Gly Pro Pro Ala Ala Arg Ala Gly Ala Gly Thr Ala Ala Leu Leu Arg Gly Pro Pro Ala Ala Arg Ala Gly Ala Gly Thr Ala
20 25 30 20 25 30
the
the
Gly Ala Gly Pro Val Val Arg Cys Glu Pro Cys Asp Ala Arg Ala Val Gly Ala Gly Pro Val Val Arg Cys Glu Pro Cys Asp Ala Arg Ala Val
35 40 45 35 40 45 45
the
the
Ala Gln Cys Ala Pro Pro Pro Pro Ser Pro Pro Cys Thr Glu Leu Val Ala Gln Cys Ala Pro Pro Pro Pro Pro Ser Pro Pro Cys Thr Glu Leu Val
50 55 60 50 55 60 60
the
the
Arg Glu Pro Gly Cys Gly Cys Cys Leu Thr Cys Ala Leu Arg Glu Gly Arg Glu Pro Gly Cys Gly Cys Cys Leu Thr Cys Ala Leu Arg Glu Gly
65 70 75 80 65 70 75 80
the
the
Gln Pro Cys Gly Val Tyr Thr Glu Arg Cys Gly Ser Gly Leu Arg Cys Gln Pro Cys Gly Val Tyr Thr Glu Arg Cys Gly Ser Gly Leu Arg Cys
85 90 95 85 90 95
the
the
Gln Pro Pro Pro Gly Asp Pro Arg Pro Leu His Ala Leu Leu Asp Gly Gln Pro Pro Pro Gly Asp Pro Arg Pro Leu His Ala Leu Leu Asp Gly
100 105 110 100 105 110
the
the
Arg Gly Leu Cys Ala Asn Ala Ser Ala Val Gly Arg Leu Ser Pro Tyr Arg Gly Leu Cys Ala Asn Ala Ser Ala Val Gly Arg Leu Ser Pro Tyr
115 120 125 115 120 125
the
the
Leu Leu Pro Ala Pro Pro Ala Pro Gly Asn Gly Ser Glu Ser Glu Glu Leu Leu Pro Ala Pro Pro Ala Pro Gly Asn Gly Ser Glu Ser Glu Glu
130 135 140 130 135 140
the
the
Asp His Ser Met Gly Ser Thr Glu Asn Gln Ala Leu Pro Thr Thr Arg Asp His Ser Met Gly Ser Thr Glu Asn Gln Ala Leu Pro Thr Thr Arg
145 150 155 160 145 150 155 160
the
the
Arg Val Pro Asp Ser Lys Ser His Leu Ala His Thr Lys Met Asp Val Arg Val Pro Asp Ser Lys Ser His Leu Ala His Thr Lys Met Asp Val
165 170 175 165 170 175
the
the
Ile Lys Lys Gly His Ala Lys Asp Ser Gln Arg Tyr Lys Val Asp Tyr Ile Lys Lys Gly His Ala Lys Asp Ser Gln Arg Tyr Lys Val Asp Tyr
180 185 190 180 185 190
the
the
Glu Ser Gln Ser Thr Asp Thr Gln Asn Phe Ser Ser Glu Ser Lys His Glu Ser Gln Ser Thr Asp Thr Gln Asn Phe Ser Ser Glu Ser Lys His
195 200 205 195 200 205
the
the
Glu Thr Glu Tyr Gly Pro Cys Arg Arg Glu Met Glu Asp Thr Leu Asn Glu Thr Glu Tyr Gly Pro Cys Arg Arg Glu Met Glu Asp Thr Leu Asn
210 215 220 210 215 220
the
the
Asp Leu Lys Phe Leu Asn Thr Leu Ser Pro Arg Ala Ile His Ile Pro Asp Leu Lys Phe Leu Asn Thr Leu Ser Pro Arg Ala Ile His Ile Pro
225 230 235 240 225 230 235 240
the
the
Asn Cys Asp Lys Lys Gly Phe Tyr Lys Lys Lys Gln Cys Arg Pro Ser Asn Cys Asp Lys Lys Gly Phe Tyr Lys Lys Lys Gln Cys Arg Pro Ser
245 250 255 245 250 255
the
the
Lys Gly Arg Lys Arg Gly Phe Cys Trp Cys Val Asp Lys Tyr Gly Gln Lys Gly Arg Lys Arg Gly Phe Cys Trp Cys Val Asp Lys Tyr Gly Gln
260 265 270 260 265 270
the
the
Pro Leu Pro Ala Phe Ser Val Lys Gly Lys Gly Asp Val His Cys Leu Pro Leu Pro Ala Phe Ser Val Lys Gly Lys Gly Asp Val His Cys Leu
275 280 285 275 280 285
the
the
Ser Thr Glu Ser Lys Ser Thr Glu Ser Lys
290 290
the
the
<210> 3 <210> 3
<211> 18 <211> 18
<212> DNA <212> DNA
<213> 山羊 <213> goat
the
<400> 3 <400> 3
agctcgctgc cgcccagt 18 agctcgctgc cgcccagt 18
the
the
<210> 4 <210> 4
<211> 20 <211> 20
<212> DNA <212> DNA
<213> 山羊 <213> goat
the
<400> 4 <400> 4
gctgatcatg tccttggcag 20 gctgatcatg tccttggcag 20
the
the
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310294920.4A CN104293766A (en) | 2013-07-15 | 2013-07-15 | Method of cloning goat IGFBP3 gene cDNA coding sequence |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310294920.4A CN104293766A (en) | 2013-07-15 | 2013-07-15 | Method of cloning goat IGFBP3 gene cDNA coding sequence |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104293766A true CN104293766A (en) | 2015-01-21 |
Family
ID=52313721
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310294920.4A Pending CN104293766A (en) | 2013-07-15 | 2013-07-15 | Method of cloning goat IGFBP3 gene cDNA coding sequence |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104293766A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105112527A (en) * | 2015-08-28 | 2015-12-02 | 南京农业大学 | Molecular identification method for Biluochun tea |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001032920A2 (en) * | 1999-11-03 | 2001-05-10 | Metris Therapeutics Limited | Agents implicated in endometriosis |
EP1141014A1 (en) * | 1999-01-06 | 2001-10-10 | Genentech, Inc. | Insulin-like growth factor (igf) i mutant variants |
-
2013
- 2013-07-15 CN CN201310294920.4A patent/CN104293766A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1141014A1 (en) * | 1999-01-06 | 2001-10-10 | Genentech, Inc. | Insulin-like growth factor (igf) i mutant variants |
WO2001032920A2 (en) * | 1999-11-03 | 2001-05-10 | Metris Therapeutics Limited | Agents implicated in endometriosis |
Non-Patent Citations (1)
Title |
---|
周明亮: "绵羊IGFBP家族基因克隆和IGF系统基因的时空表达谱及IGF-Ⅰ与体重性状的相关分析研究", 《中国博士学位论文全文数据库 农业科技辑》, 15 July 2010 (2010-07-15) * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105112527A (en) * | 2015-08-28 | 2015-12-02 | 南京农业大学 | Molecular identification method for Biluochun tea |
CN105112527B (en) * | 2015-08-28 | 2018-06-19 | 南京农业大学 | A kind of method for identifying molecules of Pilochun (a green tea) commodity tea |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106636047B (en) | A kind of protein being catalyzed alanine decarboxylation and its gene and application | |
CN110747200A (en) | Nucleotide sequence, primer and method for inhibiting candida albicans protein by quinoa | |
CN102268437A (en) | Method for cloning complete sequence of goat MC4R gene coding region | |
CN104293766A (en) | Method of cloning goat IGFBP3 gene cDNA coding sequence | |
CN104098687A (en) | Pig FTO recombinant protein and preparation method thereof | |
CN108558994A (en) | Portunus trituberculatus Miers C1q receptor PtgC1qR genes and its coding albumen and application | |
CN103739696B (en) | Cynoglossus semilaevis female specificity CSW3 protein as well as gene and application thereof | |
CN108977455B (en) | Recombinant plasmid for producing oxalate decarboxylase, Escherichia coli expression system and method and application | |
JP4158956B2 (en) | Method for producing gene encoding protein having ability to regenerate luciferin, recombinant DNA and protein having ability to regenerate luciferin | |
CN110669114A (en) | A kind of lanthiopeptide precursor peptide amyA6 and its preparation method and application | |
CN101988065A (en) | Haliotis diversicolor calmodulin cDNA sequence | |
CN100596307C (en) | A kind of chicken silk feather trait gene and its application | |
CN104293767A (en) | Method of cloning complete sequence of coding region of goat IGFBP2 gene | |
CN111304177B (en) | Preparation method and application of recombinant protein swHO1 | |
CN109022471B (en) | Escherichia coli expression system for producing oxalate oxidase, and production method and application of oxalate oxidase | |
CN101245345B (en) | Goat S6K1 gene cDNA encoding zone nucleotide sequence | |
CN114671943B (en) | Preparation and application of fish ingestion regulating protein | |
CN114752617B (en) | Method for constructing recombinant expression vector, engineering bacterium and expression system | |
CN104293795A (en) | MYL4 gene capable of regulating and controlling growth of dorper skeletal muscle and application thereof | |
CN110946877A (en) | A stem cell biological product for treating liver cirrhosis and its preparation method and application | |
CN115044599B (en) | Streptococcus agalactiae strain delta ess C and construction method and application thereof | |
CN114395545B (en) | Sialidase for resisting helicobacter pylori colonization in stomach | |
CN110511933A (en) | A rat long non-coding lncRNA-lncMSTRG10078 and its application against cell damage | |
CN116103302B (en) | Lepidium longicorn Ir2 gene and application thereof | |
CN115820603B (en) | DCasRx-NSUN6 single-gene-specific M5C modification editing method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20150121 |
|
WD01 | Invention patent application deemed withdrawn after publication |